Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
about
Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayerStereoselective HDAC inhibition from cysteine-derived zinc-binding groups.Transcriptional profiles in liver from rats treated with tumorigenic and non-tumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.
P2860
Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Dual-action hypoglycemic and h ...... se and lanosterol demethylase.
@en
type
label
Dual-action hypoglycemic and h ...... se and lanosterol demethylase.
@en
prefLabel
Dual-action hypoglycemic and h ...... se and lanosterol demethylase.
@en
P2093
P2860
P1476
Dual-action hypoglycemic and h ...... se and lanosterol demethylase.
@en
P2093
Bernard Hulin
Dayna C Mankowski
Dennis J Hoover
E Michael Gibbs
Eliot D Sugarman
H James Harwood
James T Mayne
Judith L Treadway
Stephen F Petras
Victor F Soliman
P2860
P304
P356
10.1194/JLR.M400436-JLR200
P577
2004-12-16T00:00:00Z